Stay updated with breaking news from Expanded Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Heidelberg Pharma AG / Key word: 9 Month figures Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023 12.10.2023 /...
EQS-News: Heidelberg Pharma AG / Key word(s): 9 Month figuresHeidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023 12.10.2023 / 07:09 CET/CESTThe issuer is solely responsible for the content of this announcement.Heidelberg Pharma AG: Interim Management Statement on the First Nine Months...
TEL AVIV, Israel & RALEIGH, N.C., Sept. 22, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that on
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that on September...
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, announced the U.S. Food and Drug...